{
    "hands_on_practices": [
        {
            "introduction": "Decision tree analysis is a cornerstone of health economic modeling, providing a clear visual and quantitative framework for comparing different strategies. This first practice problem challenges you to build and analyze a simple decision tree for a preventive screening program . By calculating the expected costs and health outcomes for each strategy, you will learn to apply the concept of Net Monetary Benefit to determine the most cost-effective choice, a fundamental skill for evaluating public health interventions.",
            "id": "4531071",
            "problem": "A preventive medicine program is evaluating two strategies for managing a condition over a one-year horizon using a decision tree. Strategy A is a screening test with two possible outcomes: early detection with probability $0.3$ and missed detection with probability $0.7$. If early detection occurs, the immediate cost is $\\$500$ and the individual's one-year health-related quality is quantified as $0.9$ quality-adjusted life years (QALYs). If detection is missed, the immediate cost is $\\$200$ and the one-year QALY is $0.7$. Strategy B involves no test, with a single outcome: cost $\\$0$ and one-year QALY $0.8$. Using the definition of expected value for a discrete random variable, compute the expected one-year cost and expected one-year QALY for each strategy. Then, using the concept of net monetary benefit under a willingness-to-pay threshold, compare the strategies under a willingness-to-pay of $\\lambda=\\$50{,}000$ per QALY to determine which strategy is preferred. Finally, report the net monetary benefit difference defined as the net monetary benefit of Strategy B minus the net monetary benefit of Strategy A. Round the reported difference to four significant figures and express the number in United States dollars (USD).",
            "solution": "The problem statement is a well-defined exercise in health economic modeling, specifically using decision analysis. It provides all necessary parameters and defines the objectives clearly. It is scientifically grounded in the principles of decision theory, expected value, and cost-effectiveness analysis using net monetary benefit. The problem is self-contained, internally consistent, and free of ambiguity. Therefore, it is deemed valid.\n\nThe problem asks for the computation of expected costs and quality-adjusted life years (QALYs) for two strategies, followed by a comparison using the net monetary benefit (NMB) framework and a specific willingness-to-pay threshold.\n\nFirst, I will define the given parameters symbolically.\n\nFor Strategy A (screening test):\n- Probability of early detection: $p_{ed} = 0.3$\n- Cost of early detection: $C_{ed} = 500$ USD\n- QALYs with early detection: $Q_{ed} = 0.9$\n- Probability of missed detection: $p_{md} = 0.7$\n- Cost of missed detection: $C_{md} = 200$ USD\n- QALYs with missed detection: $Q_{md} = 0.7$\nNote that the probabilities of the two outcomes for Strategy A sum to unity: $p_{ed} + p_{md} = 0.3 + 0.7 = 1$.\n\nFor Strategy B (no test):\n- Cost of no test: $C_B = 0$ USD\n- QALYs with no test: $Q_B = 0.8$\n\nThe willingness-to-pay threshold is given as $\\lambda = 50,000$ USD per QALY.\n\nThe analysis proceeds in four steps:\n1. Calculate the expected cost and expected QALY for Strategy A.\n2. Identify the expected cost and expected QALY for Strategy B.\n3. Calculate the Net Monetary Benefit (NMB) for each strategy.\n4. Calculate the difference in NMB as specified.\n\nStep 1: Expected Values for Strategy A\nThe expected value of a discrete random variable is the sum of the value of each outcome multiplied by its probability.\nThe expected cost of Strategy A, denoted $E[C_A]$, is calculated as:\n$$E[C_A] = (p_{ed} \\times C_{ed}) + (p_{md} \\times C_{md})$$\nSubstituting the given values:\n$$E[C_A] = (0.3 \\times 500) + (0.7 \\times 200) = 150 + 140 = 290$$\nSo, the expected cost for Strategy A is $290$ USD.\n\nThe expected QALYs for Strategy A, denoted $E[Q_A]$, is calculated similarly:\n$$E[Q_A] = (p_{ed} \\times Q_{ed}) + (p_{md} \\times Q_{md})$$\nSubstituting the given values:\n$$E[Q_A] = (0.3 \\times 0.9) + (0.7 \\times 0.7) = 0.27 + 0.49 = 0.76$$\nSo, the expected QALYs for Strategy A is $0.76$.\n\nStep 2: Expected Values for Strategy B\nStrategy B has only one outcome, which occurs with a probability of $1$. Therefore, its expected values are simply the values for that single outcome.\nThe expected cost of Strategy B is $E[C_B] = C_B = 0$ USD.\nThe expected QALYs for Strategy B is $E[Q_B] = Q_B = 0.8$.\n\nStep 3: Net Monetary Benefit Calculation\nThe Net Monetary Benefit (NMB) is a measure used to evaluate cost-effectiveness. It is defined as:\n$$NMB = (\\lambda \\times E[Q]) - E[C]$$\nA strategy is considered cost-effective relative to another if it has a higher NMB.\n\nFor Strategy A, the NMB is:\n$$NMB_A = (\\lambda \\times E[Q_A]) - E[C_A]$$\nSubstituting the calculated expected values and the given $\\lambda$:\n$$NMB_A = (50,000 \\times 0.76) - 290 = 38,000 - 290 = 37,710$$\nThe NMB for Strategy A is $37,710$ USD.\n\nFor Strategy B, the NMB is:\n$$NMB_B = (\\lambda \\times E[Q_B]) - E[C_B]$$\nSubstituting the values:\n$$NMB_B = (50,000 \\times 0.8) - 0 = 40,000 - 0 = 40,000$$\nThe NMB for Strategy B is $40,000$ USD.\n\nStep 4: Comparison and Final Calculation\nComparing the NMB of the two strategies, we find that $NMB_B > NMB_A$ ($40,000 > 37,710$). This indicates that Strategy B (no test) is the preferred strategy under the given willingness-to-pay threshold.\n\nThe problem asks for the net monetary benefit difference, defined as $NMB_B - NMB_A$.\n$$\\text{Difference} = NMB_B - NMB_A = 40,000 - 37,710 = 2,290$$\nThe difference is $2,290$ USD. The problem requires rounding this result to four significant figures. The number $2,290$ is an exact integer. It can be written as $2.290 \\times 10^3$, which explicitly shows four significant figures, assuming the trailing zero is significant. Given the context of rounding to a specified precision, treating the result as $2290$ with four significant figures is the correct interpretation.",
            "answer": "$$\\boxed{2290.}$$"
        },
        {
            "introduction": "While decision trees are excellent for one-time decisions, many health conditions evolve over time. This is where Markov models become essential tools, allowing us to simulate how a group of people, or a cohort, moves between different health states over multiple cycles . In this exercise, you will construct a transition probability matrix—the engine of the Markov model—and use it to project the cohort's health status after one year, mastering the basic principles of cohort simulation.",
            "id": "4531055",
            "problem": "A public health team is building a discrete-time cohort Markov model to support a preventive medicine decision analysis for a chronic condition. The model has $3$ mutually exclusive and collectively exhaustive health states: Healthy ($H$), Diseased ($D$), and Dead ($X$). The cycle length is one year. For program planning, the team specifies the following scientifically plausible one-cycle transition probabilities based on surveillance data and clinical judgment:\n\n- From $H$: the probability of incident disease is $0.04$ and the probability of death is $0.01$ in one cycle.\n- From $D$: the probability of remission to $H$ is $0.15$ and the probability of death is $0.05$ in one cycle.\n- From $X$: the state is absorbing.\n\nUsing only foundational definitions for discrete-time Markov cohort models in health economics (rows represent current-state origin and must sum to $1$; the absorbing state satisfies $p_{XX}=1$ and $p_{Xj}=0$ for $j \\neq X$), construct a valid $3 \\times 3$ transition probability matrix $P$ in the state order $(H,D,X)$. Then, assuming the initial cohort distribution is entirely Healthy, represented as a row vector $s_{0} = [1,\\,0,\\,0]$ in the same state order, determine the one-cycle cohort distribution $s_{1}$.\n\nReport only the one-cycle cohort distribution vector $s_{1}$ in the order $(H,D,X)$. Do not round; provide exact decimal values as specified.",
            "solution": "The problem statement has been validated and is deemed valid. It is scientifically grounded, well-posed, objective, and contains sufficient information to derive a unique solution without contradictions.\n\nThe problem requires the construction of a $3 \\times 3$ one-cycle transition probability matrix, $P$, for a discrete-time cohort Markov model and the calculation of the cohort distribution after one cycle, $s_1$. The health states are ordered as Healthy ($H$), Diseased ($D$), and Dead ($X$).\n\nThe transition matrix $P$ is constructed such that its element $P_{ij}$ represents the probability of transitioning from state $i$ to state $j$ in one cycle. A fundamental property of a stochastic matrix is that the sum of the probabilities in each row must equal $1$.\n\nFirst, we determine the probabilities for the first row of $P$, which corresponds to transitions from the Healthy ($H$) state. We are given:\n- The probability of transitioning from Healthy to Diseased, $p_{HD} = 0.04$.\n- The probability of transitioning from Healthy to Dead, $p_{HX} = 0.01$.\n\nThe probability of remaining in the Healthy state, $p_{HH}$, is calculated by ensuring the sum of the row is $1$:\n$$p_{HH} + p_{HD} + p_{HX} = 1$$\n$$p_{HH} = 1 - p_{HD} - p_{HX} = 1 - 0.04 - 0.01 = 0.95$$\nThus, the first row of matrix $P$ is $\\begin{pmatrix} 0.95 & 0.04 & 0.01 \\end{pmatrix}$.\n\nSecond, we determine the probabilities for the second row of $P$, corresponding to transitions from the Diseased ($D$) state. We are given:\n- The probability of transitioning from Diseased to Healthy (remission), $p_{DH} = 0.15$.\n- The probability of transitioning from Diseased to Dead, $p_{DX} = 0.05$.\n\nThe probability of remaining in the Diseased state, $p_{DD}$, is:\n$$p_{DD} + p_{DH} + p_{DX} = 1$$\n$$p_{DD} = 1 - p_{DH} - p_{DX} = 1 - 0.15 - 0.05 = 0.80$$\nThus, the second row of matrix $P$ is $\\begin{pmatrix} 0.15 & 0.80 & 0.05 \\end{pmatrix}$.\n\nThird, we determine the probabilities for the third row of $P$, corresponding to transitions from the Dead ($X$) state. The state $X$ is defined as absorbing. This implies that once a member of the cohort enters this state, they cannot leave. Therefore:\n- The probability of remaining in the Dead state is $p_{XX} = 1$.\n- The probabilities of transitioning from Dead to any other state are zero: $p_{XH} = 0$ and $p_{XD} = 0$.\nThus, the third row of matrix $P$ is $\\begin{pmatrix} 0 & 0 & 1 \\end{pmatrix}$.\n\nCombining these rows, the complete transition probability matrix $P$ is:\n$$P = \\begin{pmatrix} p_{HH} & p_{HD} & p_{HX} \\\\ p_{DH} & p_{DD} & p_{DX} \\\\ p_{XH} & p_{XD} & p_{XX} \\end{pmatrix} = \\begin{pmatrix} 0.95 & 0.04 & 0.01 \\\\ 0.15 & 0.80 & 0.05 \\\\ 0 & 0 & 1 \\end{pmatrix}$$\n\nThe initial cohort distribution is given as a row vector $s_0$, where the cohort is entirely Healthy:\n$$s_0 = \\begin{pmatrix} 1 & 0 & 0 \\end{pmatrix}$$\n\nThe cohort distribution after one cycle, $s_1$, is found by post-multiplying the initial state vector $s_0$ by the transition matrix $P$:\n$$s_1 = s_0 P$$\n$$s_1 = \\begin{pmatrix} 1 & 0 & 0 \\end{pmatrix} \\begin{pmatrix} 0.95 & 0.04 & 0.01 \\\\ 0.15 & 0.80 & 0.05 \\\\ 0 & 0 & 1 \\end{pmatrix}$$\n\nThe matrix multiplication yields:\nThe first component of $s_1$: $(1)(0.95) + (0)(0.15) + (0)(0) = 0.95$.\nThe second component of $s_1$: $(1)(0.04) + (0)(0.80) + (0)(0) = 0.04$.\nThe third component of $s_1$: $(1)(0.01) + (0)(0.05) + (0)(1) = 0.01$.\n\nTherefore, the one-cycle cohort distribution vector $s_1$ is:\n$$s_1 = \\begin{pmatrix} 0.95 & 0.04 & 0.01 \\end{pmatrix}$$\nThis vector represents the proportion of the cohort in the Healthy, Diseased, and Dead states, respectively, after one year. The sum of its components is $0.95 + 0.04 + 0.01 = 1$, as required for a probability distribution.",
            "answer": "$$\\boxed{\\begin{pmatrix} 0.95 & 0.04 & 0.01 \\end{pmatrix}}$$"
        },
        {
            "introduction": "Our models are only as good as their underlying assumptions. A standard discrete-time Markov model assumes events occur at the end of a cycle, which can introduce bias when costs and health effects actually accrue continuously. This exercise explores the half-cycle correction, a widely used technique to improve model accuracy by assuming events occur, on average, midway through a cycle . By quantifying the difference between an uncorrected model and one using this correction, you will gain a deeper appreciation for the nuances of building realistic and reliable health economic models.",
            "id": "4531010",
            "problem": "A preventive medication is evaluated using a discrete-time Markov cohort model with cycle length $1$ year. Individuals begin the model in the state \"On Treatment\" and can transition to \"Dropped Out\" due to attrition. Assume no mortality, no re-initiation after dropout, and no costs beyond those incurred while on treatment. Let the annual treatment cost while adherent be $c = 1200$ United States dollars (USD) per year. Attrition is high in the first year: the probability of dropping out at some point during the first year is $p_{1} = 0.6$. Conditional on remaining on treatment at the start of the second year, the probability of dropping out during the second year is $p_{2} = 0.2$. Consider a $2$-year horizon.\n\nTwo costing approaches are considered:\n\n1. An uncorrected discrete-time approach in which any individual who starts a cycle on treatment is charged the full annual cost for that cycle, regardless of mid-cycle dropout.\n\n2. A Half-Cycle Correction (HCC) approach that approximates continuous accrual by assuming that events (dropouts) occur uniformly within each cycle and adjusts expected time on treatment accordingly within each cycle, before multiplying by the annual cost $c$.\n\nUsing the fundamental definitions of expected cost as the product of the cost rate and the expected occupancy time in the cost-incurring state, compute the per-person bias defined as the uncorrected expected total cost minus the half-cycle corrected expected total cost over the $2$-year horizon. Express your final answer in United States dollars (USD). Round your answer to four significant figures.",
            "solution": "The user has provided a problem in health economic modeling that requires the calculation of the bias between two different costing methodologies in a discrete-time Markov model. The problem has been validated and is deemed sound, well-posed, and formalizable.\n\nThe problem asks for the bias, which is defined as the difference between the expected total cost calculated using an uncorrected discrete-time approach and a half-cycle corrected (HCC) approach. We will calculate the expected cost for each approach over the $2$-year horizon and then find their difference.\n\nLet $c$ be the annual cost of treatment, given as $c = 1200$ USD.\nLet $p_1$ be the probability of dropping out during the first year, given as $p_1 = 0.6$.\nLet $p_2$ be the probability of dropping out during the second year, conditional on being on treatment at the start of the second year, given as $p_2 = 0.2$.\nThe model has two states: \"On Treatment\" (OT) and \"Dropped Out\" (DO). The entire cohort starts in the OT state.\n\nFirst, let's determine the proportion of the cohort in the \"On Treatment\" state at the beginning of each year. Let $S(t)$ be the proportion of the initial cohort in the OT state at the start of year $t+1$ (where $t=0$ represents the start of year 1).\nThe entire cohort begins in the OT state, so the proportion at the start of year $1$ is $S(0) = 1$.\nThe proportion remaining on treatment at the end of year $1$ (and thus at the start of year $2$) is the proportion that did not drop out:\n$S(1) = S(0) \\times (1 - p_1) = 1 - p_1 = 1 - 0.6 = 0.4$.\n\nWe will now calculate the expected cost under each approach.\n\n**1. Uncorrected Discrete-Time Approach ($E[C_{U}]$)**\n\nIn this approach, the full annual cost $c$ is applied if an individual starts the cycle in the \"On Treatment\" state, regardless of whether they drop out during that cycle.\n\n- **Year 1:** The entire cohort (proportion $1$) starts in the OT state. Thus, the expected cost per person for year $1$ is $E[C_{U,1}] = 1 \\times c = c$.\n- **Year 2:** The proportion of the cohort starting year $2$ in the OT state is $S(1) = 1 - p_1$. This proportion incurs the full annual cost $c$. The expected cost per person for year $2$ is $E[C_{U,2}] = S(1) \\times c = (1 - p_1)c$.\n\nThe total expected uncorrected cost over the $2$-year horizon is the sum of the expected costs for each year:\n$$E[C_{U}] = E[C_{U,1}] + E[C_{U,2}] = c + (1 - p_1)c = c(1 + 1 - p_1) = c(2 - p_1)$$\n\n**2. Half-Cycle Correction (HCC) Approach ($E[C_{HCC}]$)**\n\nThis approach approximates the cost by multiplying the cost rate $c$ by the expected time spent in the \"On Treatment\" state during each cycle. Assuming dropouts occur uniformly throughout a cycle, an individual who drops out during a cycle is expected to have spent half a cycle ($0.5$ years) on treatment.\n\n- **Year 1:** A proportion $p_1$ of the cohort drops out, spending an average of $0.5$ years on treatment. A proportion $(1-p_1)$ remains on treatment for the full $1$ year. The expected time on treatment in year $1$, $T_1$, is:\n$T_1 = p_1 \\times 0.5 + (1-p_1) \\times 1 = 0.5p_1 + 1 - p_1 = 1 - 0.5p_1$.\nThe expected cost for year $1$ is $E[C_{HCC,1}] = c \\times T_1 = c(1 - 0.5p_1)$.\n\n- **Year 2:** This analysis applies to the sub-cohort of size $S(1) = 1 - p_1$ that started the year on treatment. For this sub-cohort, a proportion $p_2$ drops out (spending $0.5$ years) and a proportion $(1-p_2)$ remains for the full year. The expected time on treatment *for an individual who starts year 2* is $1 - 0.5p_2$.\nTo find the expected time on treatment in year $2$ for the entire original cohort, $T_2$, we multiply this by the probability of starting year $2$ on treatment:\n$T_2 = S(1) \\times (1 - 0.5p_2) = (1 - p_1)(1 - 0.5p_2)$.\nThe expected cost for year $2$ is $E[C_{HCC,2}] = c \\times T_2 = c(1 - p_1)(1 - 0.5p_2)$.\n\nThe total expected HCC cost is the sum of the costs for each year:\n$$E[C_{HCC}] = E[C_{HCC,1}] + E[C_{HCC,2}] = c(1 - 0.5p_1) + c(1 - p_1)(1 - 0.5p_2)$$\n\n**3. Calculation of the Bias**\n\nThe bias is defined as the difference between the uncorrected and HCC expected costs.\nBias $= E[C_{U}] - E[C_{HCC}]$\nBias $= c(2 - p_1) - \\left[ c(1 - 0.5p_1) + c(1 - p_1)(1 - 0.5p_2) \\right]$\nWe can factor out $c$:\nBias $= c \\left[ (2 - p_1) - (1 - 0.5p_1) - (1 - p_1)(1 - 0.5p_2) \\right]$\nBias $= c \\left[ 2 - p_1 - 1 + 0.5p_1 - (1 - 0.5p_2 - p_1 + 0.5p_1p_2) \\right]$\nBias $= c \\left[ 1 - 0.5p_1 - 1 + 0.5p_2 + p_1 - 0.5p_1p_2 \\right]$\nBias $= c \\left[ 0.5p_1 + 0.5p_2 - 0.5p_1p_2 \\right]$\nBias $= 0.5c (p_1 + p_2 - p_1p_2)$\n\nThis formula is intuitive. The term $(p_1 + p_2 - p_1p_2)$ represents the probability of dropping out in either year $1$ or year $2$. The bias is half the annual cost ($0.5c$) multiplied by the proportion of the cohort that ever drops out over the horizon.\n\n**4. Numerical Substitution**\n\nNow, we substitute the given values into the derived formula for the bias:\n$c = 1200$, $p_1 = 0.6$, and $p_2 = 0.2$.\n\nBias $= 0.5 \\times 1200 \\times (0.6 + 0.2 - (0.6)(0.2))$\nBias $= 600 \\times (0.8 - 0.12)$\nBias $= 600 \\times 0.68$\nBias $= 408$\n\nThe calculated bias is exactly $408$ USD. The problem requires the answer to be rounded to four significant figures. To express $408$ with four significant figures, we write it as $408.0$.",
            "answer": "$$\\boxed{408.0}$$"
        }
    ]
}